Current Neuropharmacology

Graphical Abstracts:
pp. i-iii(3)

Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons
pp. 213-218(6)
Authors: Thauerer, Bettina; zur Nedden, Stephanie; Baier-Bitterlich, Gabriele

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment
pp. 219-238(20)
Authors: Iasevoli, Felice; Tomasetti, Carmine; F. Buonaguro, Elisabetta; de Bartolomeis, Andrea

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
pp. 239-255(17)
Authors: Simone Tranches Dias, Kris; Viegas, Claudio

The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
pp. 256-268(13)
Authors: Kawalec, Pawel; Mikrut, Alicja; Wisniewska, Natalia; Pilc, Andrzej

Potential Effects of Cannabidiol as a Wake-Promoting Agent
pp. 269-272(4)
Authors: Murillo-Rodriguez, Eric; Sarro-Ramirez, Andrea; Sanchez, Daniel; Mijangos-Moreno, Stephanie; Tejeda-Padron, Alma; Poot-Ake, Alwin; Guzman, Khalil; Pacheco-Pantoja, Elda; Arias-Carrion, Oscar

Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
pp. 273-280(8)
Authors: Ribeiro-Santos, Rafael; Lucio Teixeira, Antonio; Vinicius Salgado, Joao

Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature
pp. 281-288(8)
Authors: C. Schwab, Laetitia; Luo, Vincent; L. Clarke, Chelsey; J. Nathan, Pradeep

Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
pp. 289-302(14)
Authors: Shi, Yuan; Dong, Jing-Wen; Zhao, Jiang-He; Tang, Li-Na; Zhang, Jian-Jun